Investor Presentaiton

Executives with a Proven Track Record of Success Visionary Founder, CEO and Chairman Supported by Experienced Management Team Dr. Michael Yu Founder, CEO & Chairman • Ph.D. in Genetics, Chinese Academy of Sciences Inventor of Oncorine®, Co-inventor of Conbercept and TYVYTⓇ, three innovative biologics in China Inventor of 60+ issued patents & patent applications Authorship of 50+ SCI scientific articles & book chapters 24 years of industry experience • 1997 2001: Vice President of R&D, Calydon • 2001 2005: Principal Scientist, Cell Genesys 2005: Vice President of R&D, Applied Genetics • 2006-2010: Founding President and CEO, Chengdu Kanghong Biotech 2011 to date: Founding CEO and Chairman, Innovent Biologics Dr. Yong Jun Liu President Over 30 years of academic and biopharma experience Former Head of Research, Global R&D at Sanofi and Global Head of Research, CSO at MedImmune, AZ SANOFI AstraZeneca Innvent Ronnie Ede Chief Financial Officer Former CFO of Mindray Medical International Ltd. Responsible for Finance, Investor Relation, North America Operations, and Internal Audits Former CFO of Biosensors International Ltd. mindray BIOSENSORS INTERNATIONAL™ Min Liu Chief Commercial Officer Former member of Roche Global Oncology Franchise Leadership Team Vice President of one of two Oncology Business Units at Roche Pharma China, leading marketing & sales efforts for products in lung, GI, and hematology cancers AstraZeneca Copyright©2021 Innovent Biologics Roche Vivian Zhang Chief People Officer Responsible for Human Resources, Administration, Legal, PR, GA as well as the operations of the Presidential Office Innovent 信达生物制药 12

View entire presentation